Segment Information (Tables)

9 Months Ended

Sep. 30, 2018

Selected financial info by reportable segment

Selected financial information by reportable segment is presented below (in thousands):



	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Revenues, net:
Prescription Pharmaceuticals	$	148,469		$	186,988		$	484,933		$	607,012
Consumer Health	17,156			15,440			55,699			47,976
Total revenues, net	165,625			202,428			540,632			654,988

Gross Profit:
Prescription Pharmaceuticals	50,231			91,254			197,025			328,116
Consumer Health	7,031			6,509			23,744			21,185
Total gross profit	57,262			97,763			220,769			349,301

Operating expenses	133,242			89,003			413,330			250,584

Operating (loss) income	(75,980		)	8,760			(192,561		)	98,717

Other expenses, net	(12,559		)	(10,697		)	(36,261		)	(28,578		)

(Loss) Income before income taxes	$	(88,539	)	$	(1,937	)	$	(228,822	)	$	70,139

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three and nine month periods ended September 30, 2018 and 2017. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):



	Three Months Ended September 30, 2018			Three Months Ended September 30, 2017			Nine Months Ended September 30, 2018			Nine Months Ended September 30, 2017
Region	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	161,858	97.7%	$	196,069	96.9%	$	529,598	98.0%	$	635,086	97.0%
Foreign	3,767		2.3%	6,359		3.1%	11,034		2.0%	19,902		3.0%
Total Revenues	$	165,625	100.0%	$	202,428	100.0%	$	540,632	100.0%	$	654,988	100.0%